Softgel Capsules Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.70 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Softgel Capsules Market Analysis
The Softgel Capsules Market is projected to register a CAGR of 7.7% during the forecast period (2022-2027).
The COVID-19 pandemic had a significant impact on the studied market. Softgel capsules for the treatment of COVID-19 have undergone a number of clinical trials to determine their safety and effectiveness. For instance, the clinical trial of Softgel KOVIR (TD0068) in combination with background treatment in COVID-19 patients was sponsored in October 2021 by Sao Thai Duong Joint Stock Company in association with Vietstar Biomedical Research. The study is evaluating comparative analysis between a standard dose regimen of KOVIR and a placebo combined with background treatment in COVID-19 patients. Similarly, research studies have been conducted on softgel vitamin capsules. For instance, in January 2021, a research study titled "The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design" included a daily dose of oral softgel capsule containing 3200 IU vitamin D3 to be administered daily for 4 weeks. The study stated that softgel vitamin capsules enhanced immunity and will reduce the risk of COVID-19 infection. Hence, the market is expected to grow in the upcoming future.
Factors such as technological development, rising research and development efforts, and increasing consumer demand for products are expected to increase market growth. One of the main drivers of market expansion is the advancement of research and development which increases the capability of the manufacturing of softgels now using a new technology that many businesses have created. For instance, Catalent introduced OptiGel DR technology for the formulation and production of delayed/enteric release softgels in October 2020. Pectin, a naturally occurring polysaccharide, and gelatin are combined in the to create softgel capsules, eliminating need for a separate capsule coating phase. The consequences of stomach reflux can also be reduced by the pills. It enables the softgel capsule shell to incorporate the delayed-release profile, expanding the applications and eliminating the need for a separate capsule coating phase. By doing this, coated softgel quality concerns are potentially eliminated, along with time and yield loss. Furthermore, in November 2020, Roquette launched the LYCAGEL technology, offering a pharmaceutical-grade solution for vegetarian softgel capsule formulations. Such advancements are expected to increase the market share. Hence, the abovementioned factors are expected to increase the market growth over the forecast period.
However, drawbacks associated with softgel capsules are expected to hinder market growth.
Softgel Capsules Market Trends
This section covers the major market trends shaping the Softgel Capsules Market according to our research experts:
Pharmaceutical Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Factors such as benefits over traditional dosage froms and product launches are expected to increase market growth. The softgel capsule dosage form offers several benefits over traditional dosage forms, such as delivery of a low and ultra-low doses of a compound, delivering a liquid matrix designed to solubilize and improve the oral bioavailability of a poorly soluble compound, minimization of potential generation of dust during manufacturing and thereby improving the safety of production personnel, and delivery of a low melting compound. Such are expected to increase the adoption of softgel capsules in the pharma industry and thereby driving the segment growth over the forecast period.
Product launches and capability expanson by pharmaceutical companies are also anticipated to drive the market growth. For instance, in May 2021, CBD Healthcare company Opticann launches ArthroCBD softgel capsules. ArthroCBD is a softgel capsule with 25 mg of CBD and 6 mg of Beta-caryophyllene and is formulated using VESIsorb, which provides improved 4.4x absorption versus competitive oral CBD products on the market. Similarly, in April 2020, SunISDIN Softgel Capsules were introduced by ISDIN to the United States market. With the help of the exclusive VitAox ULTRA Complex in this dietary supplement, the skin is better equipped to resist photoaging, avoid oxidative stress, and maintain overall skin health. Additionally, in August 2022, Strides Pharma Global Pte, a wholly-owned arm of the Strides Pharma has received the United States Food and Drug Administration approval for its generic naproxen sodium softgel capsules. The drug is useful to treat inflammation or pain.
Hence, the above-mentioned factors are likely to drive the pharmaceutical segment growthover the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
The North America region is expected to dominate the market owing to the increase in product approvals and agreements and acquisitions by key market players. For instance, in February 2021, Catalent signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals, a biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need, for LUPKYNIS in the United States. LUPKYNIS (voclosporin) capsules, a calcineurin-inhibitor immunosuppressant, are available for administration as soft gelatin capsules containing 7.9 mg voclosporin per capsule. Additionally, in January 2020, Strides Pharma Science Limited received approval for Loratadine Softgel Capsules, 10 mg (OTC) from the United States Food and Drug Administration (USFDA). Loratadine Softgel Capsules is an antihistamine to treat symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies. Furthermore, acquisitions are another factor in the market growth. For instance, in September 2020, Tetra Bio-Pharma Inc. entered into a definitive agreement to acquire the Canadian exclusive rights for Dronabinol Soft Gel capsules. The acquisition will allow Tetra to establish an immediate and direct commercial presence in Canada by promoting an existing prescription drug.
Hence, the above-mentioned factors are likely to propel the growth the North America over the forecast period.
Softgel Capsules Industry Overview
The market is partially fragmented and consists of several major players. Some of the companies which are currently dominating the market are Aenova Group, CAPTEK, EuroCaps, fortunelabs, Fuji Capsule Co., Ltd., MEDGEL, Procaps, SaintyCo, Sirio Pharma, and United Laboratories, among others.
Softgel Capsules Market Leaders
-
Fuji Capsule Co., Ltd.
-
Sirio Pharma
-
CAPTEK
-
United Laboratories
-
Soft Gel Technologies, Inc.
*Disclaimer: Major Players sorted in no particular order
Softgel Capsules Market News
- In May 2022, Windzor Pharma Ltd launched Rx Vitamin D3 product Solferol Softgel capsules in the Irish market. It is one of the low-cost Solferol Softgel Vitamin D3 capsules.
- In February 2022, ZYUS Life Sciences Inc. launched two softgel capsules, Zylem 1:20 Softgel Capsules and Zylem 5:5 Softgel Capsules in Canada.
Softgel Capsules Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Technological Advancements and Increasing R&D Activities
- 4.2.2 Growing Demand from Health-conscious Consumers
-
4.3 Market Restraints
- 4.3.1 Drawbacks Associated with Softgel Capsules
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Animal Based
- 5.1.2 Non-animal Based
-
5.2 By Application
- 5.2.1 Pharmaceutical
- 5.2.2 Nutraceutical
- 5.2.3 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Aenova Group
- 6.1.2 CAPTEK
- 6.1.3 EuroCaps
- 6.1.4 fortunelabs
- 6.1.5 Fuji Capsule Co., Ltd.
- 6.1.6 MEDGEL
- 6.1.7 Procaps
- 6.1.8 SaintyCo
- 6.1.9 Sirio Pharma
- 6.1.10 Soft Gel Technologies, Inc.
- 6.1.11 United Laboratories
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySoftgel Capsules Industry Segmentation
As per the scope, the softgel capsules are a gelatin-based shell containing a liquid medicament. It is used as a dosage form for a variety of medicines such as vitamins. The Softgel Capsules Market is Segmented By Type (Animal Based and Non-animal Based), Application (Pharmaceutical, Nutraceutical, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Type | Animal Based | |
| Non-animal Based | ||
| By Application | Pharmaceutical | |
| Nutraceutical | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Softgel Capsules Market Research FAQs
What is the current Global Softgel Capsules Market size?
The Global Softgel Capsules Market is projected to register a CAGR of 7.70% during the forecast period (2024-2029)
Who are the key players in Global Softgel Capsules Market?
Fuji Capsule Co., Ltd., Sirio Pharma, CAPTEK, United Laboratories and Soft Gel Technologies, Inc. are the major companies operating in the Global Softgel Capsules Market.
Which is the fastest growing region in Global Softgel Capsules Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Softgel Capsules Market?
In 2024, the North America accounts for the largest market share in Global Softgel Capsules Market.
What years does this Global Softgel Capsules Market cover?
The report covers the Global Softgel Capsules Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Softgel Capsules Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Softgel Capsules Industry Report
Statistics for the 2024 Softgel Capsules market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Softgel Capsules analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
